BROOKFIELD, Conn., Oct. 17, 2019 /PRNewswire/ -- Health Products For You (HPFY) celebrates their Golden Birthday today! A Golden or Champagne Birthday is one that occurs when

SAN DIEGO, Oct. 17, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced it will present pre-clinical data and initial clinical data on MRTX849, a novel and optimized KRAS G12C inhibitor, in presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in

LA JOLLA, Calif., Oct. 17, 2019 /PRNewswire/ -- Bird Rock Bio, Inc., a clinical stage biopharmaceutical company, announced today the successful completion of their phase

SAN DIEGO, Oct. 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc

PARSIPPANY, N.J., Oct. 17, 2019 /PRNewswire/ -- A new film entitled GATEWAY presents the story of three families inadvertently impacted by opioid addiction that began with a prescription to manage pain after surgery. The documentary, which premiered at a private screening at Helen Mills Theater in New York City on O

MANHASSET, N.Y., Oct. 17, 2019 /PRNewswire/ -- For the first time, Jacqueline Molin

TOLEDO, Ohio, Oct. 17, 2019 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) today announced that it has been granted Prime status by ISS ESG, one of the world's leading rating agencies for sustainable investments. The ISS ESG rating considers Environmental, Social and Governance ("ESG") practices by evaluating more than 100 industry-specific indicators. Companies that achiev

LOS ANGELES, Oct. 17, 2019 /PRNewswire/ -- Teijin Limited (Teijin) and

PHOENIX, Oct. 17, 2019 /PRNewswire/ -- Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannabis company with one

HOUSTON, Oct. 17, 2019 /PRNewswire/ -- American Society of Pharmacovigilance (ASP) directors today presented to key stakeholders in the field of pharmacogenomics, a detailed framework for building a national, public-private multi-disciplinary stakeholder collaboration to accelerate the development of precision medicine practices as a standard of care. The Standardizing L